Longitudinal assessment of diffusion-weighted imaging during magnetic resonance-guided radiotherapy in head and neck cancer

Abstract Background For radiotherapy of head and neck cancer (HNC) magnetic resonance imaging (MRI) plays a pivotal role due to its high soft tissue contrast. Moreover, it offers the potential to acquire functional information through diffusion weighted imaging (DWI) with the potential to personaliz...

Full description

Bibliographic Details
Published in:	Radiation Oncology
Main Authors:	Simon Boeke, Jonas Habrich, Sarah Kübler, Jessica Boldt, Fritz Schick, Konstantin Nikolaou, Jens Kübler, Cihan Gani, Maximilian Niyazi, Daniel Zips, Daniela Thorwarth
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Subjects:	MR-guided radiotherapy Apparent diffusion coefficient Quantitative magnetic resonance imaging Head and neck cancer
Online Access:	https://doi.org/10.1186/s13014-025-02589-9

Similar Items

Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation
by: Daniela Thorwarth, et al.
Published: (2020-10-01)

Full daily re-optimization improves plan quality during online adaptive radiotherapy
by: Benjamin Tengler, et al.
Published: (2024-01-01)

Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation
by: Vlatko Potkrajcic, et al.
Published: (2024-05-01)

Comparison of online adaptive and non-adaptive magnetic resonance image-guided radiation therapy in prostate cancer using dose accumulation
by: Martina Murr, et al.
Published: (2024-10-01)

Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy
by: Marcel Nachbar, et al.
Published: (2024-05-01)

Technical Challenges of Real-Time Adaptive MR-Guided Radiotherapy
by: Daniela Thorwarth, et al.
Published: (2021-03-01)

Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases
by: Laura Uder, et al.
Published: (2023-01-01)

Automatic 3D Monte-Carlo-based secondary dose calculation for online verification of 1.5 T magnetic resonance imaging guided radiotherapy
by: Marcel Nachbar, et al.
Published: (2021-07-01)

Effect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer
by: Mireille Conrad, et al.
Published: (2023-05-01)

The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours
by: Svenja Hering, et al.
Published: (2024-03-01)

Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac
by: Moritz Rabe, et al.
Published: (2024-03-01)

A body mass index-based method for “MR-only” abdominal MR-guided adaptive radiotherapy
by: Carolin Rippke, et al.
Published: (2024-08-01)

Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study
by: Almansour Haidara, et al.
Published: (2023-06-01)

Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
by: A. Mitchell, et al.
Published: (2022-07-01)

MR-Guided Adaptive Radiotherapy for Bladder Cancer
by: Adham Hijab, et al.
Published: (2021-02-01)

Leaf-individual calibration for a double stack multileaf collimator in photon radiotherapy
by: Carolin Rippke, et al.
Published: (2023-07-01)

Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma
by: Brian Keller, et al.
Published: (2021-05-01)

Retrospective review of patient factors impacting free-breathing respiratory motion magnitude for MR-guided radiotherapy
by: Mairead Daly, et al.
Published: (2025-09-01)

A simplified online adaptive workflow for long-course magnetic resonance-guided radiotherapy in esophageal cancer
by: Koen M. Kuijer, et al.
Published: (2025-01-01)

Robustness of radiomics features on 0.35 T magnetic resonance imaging for magnetic resonance-guided radiotherapy
by: Morgan Michalet, et al.
Published: (2024-07-01)

Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small-cell lung cancer: the PUMA trial
by: Sebastian Regnery, et al.
Published: (2023-05-01)

Tumor-site specific geometric distortions in high field integrated magnetic resonance linear accelerator radiotherapy
by: Signe Winther Hasler, et al.
Published: (2020-07-01)

REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study
by: Giuditta Chiloiro, et al.
Published: (2024-04-01)

Dosimetric Evaluation of Dose Calculation Uncertainties for MR-Only Approaches in Prostate MR-Guided Radiotherapy
by: Ivan Coric, et al.
Published: (2022-08-01)

MR-guided stereotactic radiation therapy for head and neck cancers
by: He Wang, et al.
Published: (2024-05-01)

Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study
by: Sweet Ping Ng, et al.
Published: (2022-08-01)

Magnetic resonance-guided adaptive stereotactic radiotherapy in prostate cancer patients: a systematic literature review
by: Sylwia Szablewska, et al.
Published: (2025-10-01)

Organs at risk proximity in central lung stereotactic ablative radiotherapy: A comparison of four-dimensional computed tomography and magnetic resonance-guided breath-hold delivery techniques
by: Nicolas Giraud, et al.
Published: (2025-04-01)

Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study
by: Luca Nicosia, et al.
Published: (2020-12-01)

Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors
by: Franziska Eckert, et al.
Published: (2019-03-01)

Comparison of beam segment versus full plan re-optimization in daily magnetic resonance imaging-guided online-adaptive radiotherapy
by: Janita E. van Timmeren, et al.
Published: (2021-01-01)

First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study
by: Daniela Gonsalves, et al.
Published: (2025-09-01)

Characterization of spatial integrity with active and passive implants in a low-field magnetic resonance linear accelerator scanner
by: Bertrand Pouymayou, et al.
Published: (2024-04-01)

Delivery of online adaptive magnetic resonance guided radiotherapy based on isodose boundaries
by: Claudio Votta, et al.
Published: (2021-04-01)

Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors
by: Nicolas Giraud, et al.
Published: (2025-09-01)

Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate
by: Lukas Nierer, et al.
Published: (2022-03-01)

Criteria for Verification and Replanning Based on the Adaptive Radiotherapy Protocol “Best for Adaptive Radiotherapy” in Head and Neck Cancer
by: Bartosz Bak, et al.
Published: (2022-05-01)

Development and comprehensive clinical validation of a deep neural network for radiation dose modelling to enhance magnetic resonance imaging guided radiotherapy
by: Moritz Schneider, et al.
Published: (2025-01-01)

Impact of motion management strategies on abdominal organ at risk delineation for magnetic resonance-guided radiotherapy
by: Mairead Daly, et al.
Published: (2024-10-01)

Consideration of image guidance in patterns of failure analyses of intensity-modulated radiotherapy for head and neck cancer: a systematic review
by: Paul-Henry Mackeprang, et al.
Published: (2024-03-01)